Last reviewed · How we verify
Bioequivalence Study of Neurogabin-M (Gabapentin 400 mg) Capsule With Parketin (Gabapentin 400 mg) Capsules (BE)
This is a single-dose, two-periods, two-sequence, two-way crossover, single oral dose bioequivalence study.
Details
| Lead sponsor | University of Karachi |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 24 |
| Start date | Fri Jun 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Sep 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Healthy Volunteers
- Bioequivalence Study
Interventions
- Neurogabin (Gabapentin) 400 mg capsule
- Parketin (Gabapentin) 400 mg capsule
Countries
Pakistan